Literature DB >> 34355183

Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram.

Gisela Andrea Camacho-Hernandez1, Andrea Casiraghi1,2, Deborah Rudin3, Dino Luethi3,4, Therese C Ku1, Daryl A Guthrie1, Valentina Straniero2, Ermanno Valoti2, Gerhard J Schütz4, Harald H Sitte3, Amy Hauck Newman1.   

Abstract

The utilization of fluorescent ligands to study the monoamine transporters (MATs) has increased our knowledge of their function and distribution in live cell systems. In this study, we extend SAR for nisoxetine and talopram as parent compounds, to identify high affinity rhodamine-labeled fluorescent probes for the norepinephrine transporter (NET). Nisoxetine-based fluorescent probe 6 demonstrated high binding affinity (K i = 43 nM) for NET and an overall selectivity compared to the other transporters for dopamine (DAT; K i = 1540 nM) and serotonin (SERT; K i = 785 nM) in competitive radioligand binding assays. Using confocal microscopy, compound 6 was shown to stain both NET and SERT, but not DAT, at low nanomolar concentrations, in transporter-expressing cells. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2021        PMID: 34355183      PMCID: PMC8292982          DOI: 10.1039/d1md00072a

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  31 in total

1.  Synaptic Vesicle Recycling Pathway Determines Neurotransmitter Content and Release Properties.

Authors:  Kätlin Silm; Jing Yang; Pamela F Marcott; Cedric S Asensio; Jacob Eriksen; Daryl A Guthrie; Amy H Newman; Christopher P Ford; Robert H Edwards
Journal:  Neuron       Date:  2019-04-16       Impact factor: 17.173

2.  Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity.

Authors:  Nancy R Keller; André Diedrich; Martin Appalsamy; Sunti Tuntrakool; Suzanna Lonce; Charlene Finney; Marc G Caron; David Robertson
Journal:  Circulation       Date:  2004-08-30       Impact factor: 29.690

3.  The N terminus of monoamine transporters is a lever required for the action of amphetamines.

Authors:  Sonja Sucic; Stefan Dallinger; Barbara Zdrazil; René Weissensteiner; Trine N Jørgensen; Marion Holy; Oliver Kudlacek; Stefan Seidel; Joo Hwan Cha; Ulrik Gether; Amy H Newman; Gerhard F Ecker; Michael Freissmuth; Harald H Sitte
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

4.  From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.

Authors:  Jonas N N Eildal; Jacob Andersen; Anders S Kristensen; Anne Marie Jørgensen; Benny Bang-Andersen; Morten Jørgensen; Kristian Strømgaard
Journal:  J Med Chem       Date:  2008-04-23       Impact factor: 7.446

5.  Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs.

Authors:  Jacob Eriksen; Søren G F Rasmussen; Trine Nygaard Rasmussen; Christian Bjerggaard Vaegter; Joo Hwan Cha; Mu-Fa Zou; Amy Hauck Newman; Ulrik Gether
Journal:  J Neurosci       Date:  2009-05-27       Impact factor: 6.167

6.  Conjugable A3 adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probes.

Authors:  Stephanie Federico; Enrico Margiotta; Stefano Moro; Eszter Kozma; Zhan-Guo Gao; Kenneth A Jacobson; Giampiero Spalluto
Journal:  Eur J Med Chem       Date:  2019-11-22       Impact factor: 6.514

7.  Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.

Authors:  Vivek Kumar; Troels Rahbek-Clemmensen; Christian B Billesbølle; Trine Nygaard Jorgensen; Ulrik Gether; Amy Hauck Newman
Journal:  ACS Med Chem Lett       Date:  2014-03-27       Impact factor: 4.345

8.  The serotonin transporter undergoes constitutive internalization and is primarily sorted to late endosomes and lysosomal degradation.

Authors:  Troels Rahbek-Clemmensen; Tina Bay; Jacob Eriksen; Ulrik Gether; Trine Nygaard Jørgensen
Journal:  J Biol Chem       Date:  2014-06-27       Impact factor: 5.157

9.  High-affinity fluorescent ligands for the 5-HT(3) receptor.

Authors:  Jonathan Simonin; Sanjeev Kumar V Vernekar; Andrew J Thompson; J Daniel Hothersall; Christopher N Connolly; Sarah C R Lummis; Martin Lochner
Journal:  Bioorg Med Chem Lett       Date:  2011-12-01       Impact factor: 2.823

10.  Targeting of dopamine transporter to filopodia requires an outward-facing conformation of the transporter.

Authors:  Shiqi Ma; Mary H Cheng; Daryl A Guthrie; Amy H Newman; Ivet Bahar; Alexander Sorkin
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

View more
  1 in total

1.  Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson's Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice.

Authors:  Andrea Casiraghi; Francesca Longhena; Gaia Faustini; Giovanni Ribaudo; Lorenzo Suigo; Gisela Andrea Camacho-Hernandez; Federica Bono; Viviana Brembati; Amy Hauck Newman; Alessandra Gianoncelli; Valentina Straniero; Arianna Bellucci; Ermanno Valoti
Journal:  Pharmaceutics       Date:  2022-07-30       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.